Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment

por Grinshpun, A., Rottenberg, Y., Ben-Dov, I.Z., Djian, E., Wolf, D.G., Kadouri, L.
Publicado 2021

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers

por Kadouri, L, Kote-Jarai, Z, Hubert, A, Baras, M, Abeliovich, D, Hamburger, T, Peretz, T, Eeles, R A
Publicado 2008

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

por Kadouri, L, Kote-Jarai, Z, Hubert, A, Durocher, F, Abeliovich, D, Glaser, B, Hamburger, T, Eeles, R A, Peretz, T
Publicado 2004

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

por Kadouri, L, Easton, D F, Edwards, S, Hubert, A, Kote-Jarai, Z, Glaser, B, Durocher, F, Abeliovich, D, Peretz, T, Eeles, R A
Publicado 2001